A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis

PHASE1UnknownINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 25, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

August 25, 2022

Conditions
Osteoarthritis, HipOsteoarthritisDegeneration
Interventions
BIOLOGICAL

Leukocyte-poor platelet rich plasma

Platelet rich plasma was prepared using PurePRP Supra Physiologic Protocol A preparation \[EmCyte Corp. Fort Myers FL\].

Trial Locations (1)

20852

RECRUITING

Regenerative Orthopedics and Sports Medicine, North Bethesda

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

EmCyte Corporation

INDUSTRY

lead

Regenerative Orthopedics and Sports Medicine

INDUSTRY